Drawing for FIRSTLINE

USPTO serial 85441892

FIRSTLINE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
LAMOTHE, LESLEY
Law office
TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with FIRSTLINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

BRIAN E. TURUNG

BRIAN E. TURUNG FAY SHARPE LLP1228 EUCLID AVECLEVELAND, OH 44115-1834UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medicine for use in the treatment and prevention of infectious diseases, asthma, allergy, and inflammatory conditions or diseases; eye drops, eyewash, eye lubricant, saline solution for contact lenses; cough and cold preparations for adults and children; allergy medication; nasal decongestants and sprays; antihistamines; antidiarrheal preparations; digestive supplements; cold and allergy liquid elixirs; laxatives; antacids; aspirin and non-aspirin cold, flu and sinus preparations; pediatric and adult pain relievers; expectorants; throat syrups; throat lozenges; cough suppressants; liquid preparations for coughs and colds; laxatives; anesthetic creams; anti-itch preparations; antibiotic preparations; athlete's foot preparations; bacitracin ointment; calamine lotion; cool/hot ointments and muscle rubs; diaper rash ointments; hydrocortisone preparations; povidone solution for use as an anti-infective; vitamins A and D ointment; vaporing ointment; zinc oxide ointment; acne medication, pads, and cream; antiseptic mouth rinse; medicated skin cream; therapeutic skin preparations; medicated powders; anti-gas and antacid preparations; heartburn relief tablets; glycerin suppositories; clortrimazole cream; antibacterial soap; capsaicin liquid; arthritis cream; medicated, dandruff, and lice killing shampoo; soap; shampoo; medicated rubbing compound; anti-allergy tablets for symptomatic relief of upper respiratory allergies; topical anesthetic creams and ointments; anti-cavity and anti-plaque mouth rinses; analgesics tablets and elixirs; all-purpose disinfecting and deodorizing preparations; antibacterial alcohol skin sanitizer gel; antibacterial cleaners; antibacterial hand lotions; antibacterial hand wash; antibacterial spray; antibiotic preparations; antifungal preparations; antiseptic liquid bandages; antiseptic preparations; antiseptic wipes; hand cleaning preparations; hand sanitizing preparations; deodorizing cleaning preparations; hand-sanitizing preparations; chemical preparations for sanitary use; deodorizing cleaning preparations; disposable wipes impregnated with disinfecting chemicals or compounds; disinfecting wipesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Sep 11, 2012MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 11, 2012ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 1, 2012GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 1, 2012GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 1, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 26, 2012DOCKASSIGNED TO EXAMINER—
Nov 8, 2011TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Nov 8, 2011PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Oct 13, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance